Candelasa, Cleofe H.
HRN: 21-37-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
MUPIROCIN 2%, 15G (TUBE)
05/24/2022
05/30/2022
TOPICAL
15gm
OD
S/P TAHBSO
Waiting Final Action
05/24/2022
CEFUROXIME 500MG (TAB)
05/24/2022
05/30/2022
ORAL
500mg
BID
S/P TAHBSO
Waiting Final Action